Search for: "Zeneca Inc."
Results 21 - 40
of 44
Sorted by Relevance
|
Sort by Date
18 Mar 2013, 4:23 am
Zeneca, Inc., 958 F. [read post]
31 May 2010, 6:16 pm
Zeneca, Inc. [read post]
10 Jan 2011, 6:35 am
Robert Pear reports in the New York Times on the Obama administration’s unexpected support for drug maker Astra Zeneca in Astra USA, Inc. v. [read post]
27 Dec 2007, 7:09 am
Zeneca, Inc., 499 F.3d 239 (3d Cir. 2007). [read post]
6 Nov 2020, 7:16 am
Mylan Pharm., Inc., 173 F.3d 829 (Fed. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
7 Feb 2019, 12:08 pm
Astra Zeneca PLC, in the Western District of Washington; United States ex rel. [read post]
9 Nov 2010, 10:52 am
See Penning- ton Seed, Inc. v. [read post]
23 Sep 2007, 2:28 pm
Zeneca, Inc., No. 05-5340, 2007 U.S. [read post]
20 Nov 2012, 7:50 am
* On Thursday 6 December, judgment will be given in Case C‑457/10 P AstraZeneca AB and Astra Zeneca plc v European Commission. [read post]
2 Dec 2011, 5:36 am
Astro-Valcour, Inc., 267 F.3d 1334 (Fed. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
17 Oct 2013, 5:00 am
Medtronic, Inc., 238 F. [read post]
2 Dec 2011, 1:11 pm
Astra-Zeneca Pharm. [read post]
21 Nov 2007, 5:21 am
Zeneca, Inc., 499 F.3d 239 (3d Cir. 2007). [read post]
2 Jun 2011, 12:46 pm
Wyeth Inc., 488 F. [read post]
6 Sep 2007, 8:13 am
Zeneca Inc., 2007 WL 2376312, at *6 (3d Cir. [read post]
4 Nov 2010, 6:14 am
Both Astra- Zeneca and Apotex rely on the testimony of Richard Fante, the president of AstraZeneca. [read post]
24 May 2007, 10:40 am
Vitek, Inc., 803 F. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
